13F Pro Quality Score

17.7/100

Rank #2,715 of 2,879 stocks

View Financials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

5.0/100

Profitability

8.3/100

Balance Sheet

8.6/100

Earnings Quality

30.0/100

Free Cash Flow

13.0/100

Institutional Flow

70.7/100

Revenue Scale

32.3/100

Dilution Risk

37.1/100

GOCO Stock Analysis & AI Quality Score

AI stock analysis and institutional research for GoHealth, Inc. (GOCO), a Financials sector company. 13F Pro's AI-powered ranking engine scores GOCO at 17.7/100 on a 32-signal composite quality model, placing it at rank #2,715 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (5.0) and profitability (8.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 37.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), GoHealth, Inc. reports quarterly revenue of $11.9M, net income of $-37.2M, free cash flow of $7.0M. Top institutional holders of GOCO by reported 13-F value include Centerbridge Partners, L.P., PUBLIC SECTOR PENSION INVESTMENT BOARD, REDWOOD CAPITAL MANAGEMENT,, based on the most recent SEC filings. GOCO trades on the Nasdaq exchange and files with the SEC under CIK 1808220. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GOCO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GoHealth, Inc. directly from SEC EDGAR. GoHealth, Inc.'s 13F Pro composite quality score has ranged between 16 and 19 since 2026, currently 17.7 — a stable long-term trajectory across 10 quarterly and live scoring snapshots.

Fun facts about GoHealth, Inc.

Quirks, history, and lore behind GOCO — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. financial services company · listed on Nasdaq · headquartered in Chicago, Illinois · operates primarily in the insurance technology space.
  • 2
    The Numbers
    Revenue in the hundreds of millions of dollars annually, though the company has faced pressure to reach profitability — a familiar story for growth-stage insurtechs.
  • 3
    The History
    Founded in the late 2000s, it rode the wave of the Affordable Care Act boom, building a platform to connect consumers with health insurance options at scale.
  • 4
    The Secret
    It doesn't actually sell insurance — it sells access to insurance, acting as a tech-enabled marketplace that earns commissions by matching shoppers with health plans.
  • 5
    The Lore
    It went public via a 2020 IPO during peak insurtech mania, briefly surging before the market sobered up and reminded everyone that Medicare Advantage margins are not a growth hack.
  • 6
    The Giveaway
    Its ticker literally spells out its mission: helping people find health insurance coverage online — think of it as the marketplace for your Medicare and ACA plans, with "Go" and "Health" baked right into the name.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$11.9M

Net Income

Q1 2026

$-37.2M

Free Cash Flow

Q1 2026

$7.0M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-54.7% YoY
$361.8MFY 2025
FY21 $1.06BFY22 $631.7MFY24 $798.9MFY25 $361.8M

Net Income

-8681.6% YoY
$-257.1MFY 2025
FY21 $-189.4MFY22 $-148.7MFY24 $-2.9MFY25 $-257.1M

Operating Income

-5759.2% YoY
$-412.9MFY 2025
FY21 $-489.4MFY22 $-318.7MFY24 $-7.0MFY25 $-412.9M

EPS (Diluted)

-2956.1% YoY
$-20.17FY 2025
FY21 $-26.80FY22 $-17.72FY24 $-0.66FY25 $-20.17

Total Assets

-33.7% YoY
$987.4MFY 2025
FY21 $2.07BFY22 $1.66BFY24 $1.49BFY25 $987.4M

Total Debt

+20.9% YoY
$636.7MFY 2025
FY21 $675.7MFY22 $515.4MFY24 $526.9MFY25 $636.7M

Op. Cash Flow

-464.4% YoY
$-121.9MFY 2025
FY21 $-299.0MFY22 $60.9MFY24 $-21.6MFY25 $-121.9M

Get alerted when GOCO's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for GoHealth, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of GOCO

Put GOCO on your watchlist

Track score changes the day GoHealth, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is GOCO a good stock to buy?

13F Pro's AI-powered analysis of GoHealth, Inc. (GOCO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GOCO are available on the GOCO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own GOCO?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GOCO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GoHealth, Inc.'s investment landscape.